GlobalGov › Germany › Pharmaceuticals › Solicitation

Germany – Pharmaceutical products – Arzneimittel mit dem Wirkstoff Treprostinil (ATC: B01AC21)

Health · Germany government procurement

Closed August 30, 2026. GlobalGov surfaces government procurement from around the world, including the markets your competitors overlook.

Closed
Status

About this record

The issuing agency did not publish a description for this notice. The full record as GlobalGov received it is below.

Your competitors are watching the same crowded contracts everyone else is. Track live opportunities like this one worldwide, set deadline alerts, and win where they aren’t. Free for 14 days, no card.

Start Free

Solicitation Details

Issuing agencyHealth
CountryGermany
CategoryPharmaceuticals
PublishedSeptember 20, 2024
Procurement stageActive solicitation
ClosedAugust 30, 2026
StatusClosed — no longer accepting responses
Original languageGerman — members read it in their own language
Official sourceView original notice
Last verifiedOctober 09, 2026

Source: Tenders Electronic Daily (TED), © European Union. Notice content reused under Commission Decision 2011/833/EU; editorial content licensed CC BY 4.0. GlobalGov is not affiliated with the European Union.

Germany market overview →Pharmaceuticals tenders in Germany →Browse all categories →

Browse Similar Open Opportunities in Germany

Germany – Pharmaceutical products – Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Abs. 8 SGB V zum Wirkstoff Golimumab, ATC L04AB06 für die Zeit 01.07.2025 - 30.06.2027
Germany – Pharmaceutical products – Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Abs. 8 SGB V zum Wirkstoff Guanfacin, ATC N06BA21 für die Zeit 01.01.2026 - 31.12.2027 (zzgl. Verlängerungsoption 1x12 Monate)
Germany – Pharmaceutical products – Conclusion of a non-exclusive discount agreement pursuant to Section 130a Paragraph 8 of the German Social Code, Book V (SGB V) for the active ingredient oxybutynin (exclusively FER/IST), ATC G04BD04 for the period 01.04.2025 - 31.03.2027
Germany – Pharmaceutical products – Conclusion of a non-exclusive discount agreement pursuant to Section 130a Paragraph 8 of the German Social Code, Book V (SGB V) for the active ingredient doravirine, ATC J05AG06, for the period 01.12.2025 - 30.11.2027
Germany – Pharmaceutical products – Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Abs. 8 SGB V zum Wirkstoff Progesteron ausschließlich Darreichungsform VKA, (OBO) ATC G03DA04 für die Zeit 01.03.2025 - 28.02.2027
Germany – Pharmaceutical products – Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Abs. 8 SGB V zum Wirkstoff Prednisolon, ATC S01BA04 für die Zeit 01.02.2026 - 31.01.2028 (zzgl. Verlängerungsoption 1x12 Monate)
Germany – Pharmaceutical products – Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Abs. 8 SGB V zum Wirkstoff Eltrombopag, ATC B02BX05 für die Zeit 01.09.2025 - 31.08.2027 (zzgl. Verlängerungsoption 1x12 Monate)
Germany – Pharmaceutical products – Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Abs. 8 SGB V zum Wirkstoff Hydrocortison (ausschl Dafo TAB), ATC H02AB09 f.d.Z. 01.10.25-30.09.27 (zzgl.Verlängerungsoption 1x12 Monate)

See every Germany Pharmaceuticals opportunity your competition is missing. Free for 14 days.

Get real-time alerts, competitive intelligence, and deadline tracking for this and every market worldwide.

Start Free Trial — No Card Required

Free 14-day trial · no card required

See who is already competing here →

Get a free Germany Pharmaceuticals intelligence report in your inbox

A personalized report on Germany Pharmaceuticals opportunities, emailed in 5-10 minutes. One per month, no account needed.